BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 16175755)

  • 1. Psychosocial functioning and quality of life in body dysmorphic disorder.
    Phillips KA; Menard W; Fay C; Pagano ME
    Compr Psychiatry; 2005; 46(4):254-60. PubMed ID: 16175755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substance use disorders in individuals with body dysmorphic disorder.
    Grant JE; Menard W; Pagano ME; Fay C; Phillips KA
    J Clin Psychiatry; 2005 Mar; 66(3):309-16; quiz 404-5. PubMed ID: 15766296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delusional versus nondelusional body dysmorphic disorder: clinical features and course of illness.
    Phillips KA; Menard W; Pagano ME; Fay C; Stout RL
    J Psychiatr Res; 2006 Mar; 40(2):95-104. PubMed ID: 16229856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Social functioning in body dysmorphic disorder: assessment considerations.
    Didie ER; Tortolani C; Walters M; Menard W; Fay C; Phillips KA
    Psychiatr Q; 2006; 77(3):223-9. PubMed ID: 16958002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comorbidity of body dysmorphic disorder and eating disorders: severity of psychopathology and body image disturbance.
    Ruffolo JS; Phillips KA; Menard W; Fay C; Weisberg RB
    Int J Eat Disord; 2006 Jan; 39(1):11-9. PubMed ID: 16254870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of life for patients with body dysmorphic disorder.
    Phillips KA
    J Nerv Ment Dis; 2000 Mar; 188(3):170-5. PubMed ID: 10749282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of quality of life and psychosocial functioning in obsessive-compulsive disorder and body dysmorphic disorder.
    Didie ER; Walters MM; Pinto A; Menard W; Eisen JL; Mancebo M; Rasmussen SA; Phillips KA
    Ann Clin Psychiatry; 2007; 19(3):181-6. PubMed ID: 17729020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional impairment in body dysmorphic disorder: a prospective, follow-up study.
    Phillips KA; Quinn G; Stout RL
    J Psychiatr Res; 2008 Jul; 42(9):701-7. PubMed ID: 18377935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective pilot study of levetiracetam for body dysmorphic disorder.
    Phillips KA; Menard W
    CNS Spectr; 2009 May; 14(5):252-60. PubMed ID: 19407724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An open-label study of citalopram in body dysmorphic disorder.
    Phillips KA; Najjar F
    J Clin Psychiatry; 2003 Jun; 64(6):715-20. PubMed ID: 12823088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathological skin picking in individuals with body dysmorphic disorder.
    Grant JE; Menard W; Phillips KA
    Gen Hosp Psychiatry; 2006; 28(6):487-93. PubMed ID: 17088164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occupational functioning and impairment in adults with body dysmorphic disorder.
    Didie ER; Menard W; Stern AP; Phillips KA
    Compr Psychiatry; 2008; 49(6):561-9. PubMed ID: 18970904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features and correlates of major depressive disorder in individuals with body dysmorphic disorder.
    Phillips KA; Didie ER; Menard W
    J Affect Disord; 2007 Jan; 97(1-3):129-35. PubMed ID: 16893571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcome of therapist-guided internet-based cognitive behavioural therapy for body dysmorphic disorder (BDD-NET): a naturalistic 2-year follow-up after a randomised controlled trial.
    Enander J; Ljótsson B; Anderhell L; Runeborg M; Flygare O; Cottman O; Andersson E; Dahlén S; Lichtenstein L; Ivanov VZ; Mataix-Cols D; Rück C
    BMJ Open; 2019 Jan; 9(1):e024307. PubMed ID: 30647044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subthreshold body dysmorphic disorder in adolescents: Prevalence and impact.
    Schneider SC; Mond J; Turner CM; Hudson JL
    Psychiatry Res; 2017 May; 251():125-130. PubMed ID: 28199910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Body dysmorphic disorder and other clinically significant body image concerns in adolescent psychiatric inpatients: prevalence and clinical characteristics.
    Dyl J; Kittler J; Phillips KA; Hunt JI
    Child Psychiatry Hum Dev; 2006; 36(4):369-82. PubMed ID: 16741679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevalence of body dysmorphic disorder in the United States adult population.
    Koran LM; Abujaoude E; Large MD; Serpe RT
    CNS Spectr; 2008 Apr; 13(4):316-22. PubMed ID: 18408651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severity of interpersonal problems in individuals with body dysmorphic disorder.
    Didie ER; Loerke EH; Howes SE; Phillips KA
    J Pers Disord; 2012 Jun; 26(3):345-56. PubMed ID: 22686223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Personal and appearance-based rejection sensitivity in body dysmorphic disorder.
    Kelly MM; Didie ER; Phillips KA
    Body Image; 2014 Jun; 11(3):260-5. PubMed ID: 24958661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.